Opportunities to license and commercialize seven different regenerative medicine technologies will be one of the highlights of a conference in RTP next week.

On Oct. 6, Nagoya University and its RTP-based NU Tech is putting on the NU Tech Roundtable that will focus on regenerative medicine. The conference will take place at the N.C. Biotechnology Center. It begins at 8 a.m. The event is free, but registration is required.

The Technology Partnership of Nagoya University founded NU Tech, which hosted its first event in 2010.

Nagoya, which is based in Japan, is seeking to expand its presence in the U.S.

The technologies to be showcased include:

A technique to grow a variety of different tissues from a patient’s own fat tissue to a method of 3D culturing tissue.

Plus treatments for:

• Diabetes
• Arterial sclerosis
• Rheumatism
• Osteoporosis
• Cancer
• Lupus
• Muscular dystrophy
• Parkinson’s disease

“It is collaborations between universities and business enterprises that help bring new disease treatments to the marketplace,” said Tomohisa Koyama, executive director for the Technology Partnership of Nagoya University. “Making Nagoya University-developed medical technology available for commercial licensing in the Research Triangle area, expands the possibilities for developing cures for many of the diseases plaguing the world.”

The roundtable also will include presentations from six university researchers about work in the regenerative field.

Tim Bertram, chief scientific officer at Winston-Salem based Tengion is the keynote speaker.

For conference information, read here.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.